Infographic | September 9, 2022

Similarities And Differences Between The CTA And IND

Scientist lab discussion meeting GettyImages-1140779742

Deciding to submit a Clinical Trial Authorisation (CTA) or Investigational New Drug Application (IND) is a significant milestone in developing a new drug, biologic, or vaccine.

Suppose the goal of a development program is to initiate clinical trials within European member states, the United Kingdom, or North America. In that case, strategic consideration to how, when, and whether to submit a CTA or IND is critically important.

Consider the purpose, content, and procedural similarities and differences between the CTA and IND.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene